Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
Clinical trial NCT04605146 · RECRUITING
Trial details
- NCT number
- NCT04605146
- Sponsor
- Hospices Civils de Lyon
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2028-11-05
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.